Related Experiment Video

Updated: Apr 27, 2026

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer
06:24

Author Spotlight: Liujunzi Decoction as a Traditional Chinese Treatment for Coloproctitis Cancer

Published on: October 13, 2023

1.9K

Drug resistance reversed by silencing LIM domain-containing protein 1 expression in colorectal carcinoma

Zhangxing Chen1, Xiaosan Zhu2, Tao Xie1

  • 1Department of Gastroenterology, The 174th Hospital of the PLA, Xiamen University, Xiamen, Fujian 361003, USA.

Oncology Letters
|July 12, 2014
PubMed

Insights

Silencing LIM domain-containing protein 1 (LIMD1) in colorectal cancer (CRC) multidrug-resistant cells reversed resistance and increased apoptosis. This suggests targeting LIMD1 could be a new therapeutic strategy for CRC.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The role of LIM domain-containing protein 1 (LIMD1) in colorectal carcinoma (CRC) multidrug resistance (MDR) is not well understood.
  • Multidrug resistance remains a significant challenge in CRC treatment, necessitating novel therapeutic approaches.

Purpose of the Study:

  • To investigate the effect of LIMD1 silencing on the chemosensitivity of CRC MDR cells.
  • To explore the potential of targeting LIMD1 as a therapeutic strategy for overcoming CRC MDR.

Main Methods:

  • Development of 5-fluorouracil (5-FU)-resistant Colo205 and HCT-8 CRC cell lines.
  • Transfection of LIMD1 siRNA into CRC MDR cells to silence LIMD1 expression.
  • Comprehensive assessment of phenotypic changes and chemosensitivity in transfected cells.

Main Results:

  • LIMD1 expression was significantly elevated in 5-FU-resistant CRC cell lines compared to parental lines.
  • Silencing LIMD1 led to a reversal of the MDR phenotype in CRC cells.
  • Targeting LIMD1 increased 5-FU-induced apoptosis in CRC MDR cells.

Conclusions:

  • LIMD1 plays a crucial role in the multidrug resistance of colorectal carcinoma.
  • RNA interference targeting LIMD1 shows promise as a novel therapeutic strategy for overcoming CRC MDR.
  • Further research into LIMD1 inhibition could lead to improved treatment outcomes for CRC patients.
Keywords:
LIM domain-containing protein 1apoptosiscolorectal carcinomamultidrug resistance

More Related Videos

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells09:24

Silencing of BRCA2 to Identify Novel BRCA2-regulated Biological Functions in Cultured Human Cells

Published on: August 12, 2015

8.8K
Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres06:52

Discovery of Driver Genes in Colorectal HT29-derived Cancer Stem-Like Tumorspheres

Published on: July 22, 2020

6.0K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
4.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.5K